Saine, M. E., Carbonari, D. M., Newcomb, C. W., Nezamzadeh, M. S., Haynes, K., Roy, J. A., . . . Re, V. L. (2015). Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs. BMC Pharmacol Toxicol.
Citação norma ChicagoSaine, M Elle, et al. "Determinants of Saxagliptin Use Among Patients With Type 2 Diabetes Mellitus Treated With Oral Anti-diabetic Drugs." BMC Pharmacol Toxicol 2015.
Deismireacht MLASaine, M Elle, et al. "Determinants of Saxagliptin Use Among Patients With Type 2 Diabetes Mellitus Treated With Oral Anti-diabetic Drugs." BMC Pharmacol Toxicol 2015.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.